Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: Transcriptional analysis of the condition and treatment effects of zinc pyrithione

British Journal of Dermatology

Volumn 166, Issue SUPPL. 2, 2012, Pages 33-40

  Mills, Kevin J ^a   Hu, P ^a   Henry, J ^a   Tamura, M ^a   Tiesman, J P ^a   Xu, J ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; PROTEIN S 100; PYRITHIONE ZINC; S100A11 PROTEIN; SHAMPOO; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DANDRUFF; DOUBLE BLIND PROCEDURE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNITY; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SEBORRHEIC DERMATITIS; SKIN BIOPSY; STRATUM CORNEUM;

ADOLESCENT; ADULT; AGED; DERMATITIS, SEBORRHEIC; DOWN-REGULATION; GENES, MHC CLASS II; GENOMICS; HAIR PREPARATIONS; HUMANS; KERATOLYTIC AGENTS; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PYRIDINES; SCALP DERMATOSES; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84862183729     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10863.x     Document Type: Article

References (22)

1. Warner RR, Schwartz JR, Boissy Y et al. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001; 45:897-903. (Pubitemid 33096631)
2. Kerr K, Darcy T, Henry J et al. Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health. Int J Dermatol 2011; 50:102-12.
3. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15:21-57. (Pubitemid 34052580)
4. Bulmer AC, Bulmer GS. The antifungal action of dandruff shampoos. Mycopathologia 1999; 147:63-5. (Pubitemid 30615145)
5. Reygagne P, Poncet M, Sidou F et al. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis 2007; 79:397-403.
6. Piérard-Franchimont C, Piérard GE, Vroome V et al. Comparative anti-dandruff efficacy between a tar and non-tar shampoo. Dermatology 2000; 200:181-4. (Pubitemid 30199343)
7. Harding CR, Moore AE, Rogers JS et al. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res 2002; 294:221-30. (Pubitemid 34762297)
8. Rogers JS, Moore AE, Meldrum H et al. Increased scalp lipids in response to antidandruff treatment containing zinc pyrithione. Arch Dermatol Res 2003; 295:127-9. (Pubitemid 36960543)
9. Kerr K, Schwartz JR, Filloon T et al. Scalp stratum corneum histamine levels: novel sampling method reveals association with itch resolution in dandruff/seborrheic dermatitis treatment. Acta Derm Venereol (Stockh) 2011; 91:404-8.
10. Saaf AM, Tengvall-Linder M, Chang HY et al. Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One 2008; 3:e4017.
11. Gudjonsson JE, Ding J, Li X et al. Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 2009; 129:2795-804.
12. Robinson MK, Binder RL, Griffiths CEM. Genomic-driven insights into changes in aging skin. J Drugs Dermatol 2009; 8 (Suppl. 7):S8-11.
13. Billhimer WL, Bryant PD, Murray KP et al. Results of clinical trial comparing 1% pyrithione zinc and 2% ketoconazole shampoos. Cosmet Dermatol 1996; 9:34-9.
14. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 2000; 25:25-9. (Pubitemid 30257031)
15. Pico AR, Kelder T, van Iersel MP et al. WikiPathways: pathway editing for the people. PLoS Biol 2008; 6:e184.
16. Gillis J, Mistry M, Pavlidis P. Gene function analysis in complex data sets using ErmineJ. Nat Protoc 2010; 5:1148-59.
17. deBoer OJ, Wakelkamp IMMJ, Pals ST et al. Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res 1994; 286:304-11. (Pubitemid 24223610)
18. Lemini-Lopez A, Flores-Romo L, Arevalo-Lopez A et al. Altered morphology of cellular junction proteins in non-lesional psoriatic epidermis: an insight into disease severity. Arch Med Res 2006; 37:36-44. (Pubitemid 41727889)
19. Wolf R, Mascia F, Dharamsi A et al. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2008; 2:p61ra90.
20. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006; 43:159-69. (Pubitemid 44189201)
21. Spergel JM. Immunology and treatment of atopic dermatitis. Am J Clin Dermatol 2008; 9:233-44. (Pubitemid 351892371)
22. Robinson MK. Non-invasive clinical assessment of skin irritation/inflammation. In: Handbook of Cosmetic Science and Technology (Barel AO, Paye M, Maibach HI, eds), 3rd edn. New York, NY: Informa HealthCare, 2009; 481-8.